General
Investor Information
Privia Health’s stock is traded on the Nasdaq Global Select Market under the symbol PRVA.
No, Privia Health does not intend to declare or pay dividends on its capital stock in the foreseeable future.
Privia Health’s transfer agent is Equiniti Trust Company, LLC (EQ). Stockholders can contact EQ Shareowner Services at (800) 937-5449 or online at shareowneronline.com.
Our shares outstanding are reported on a quarterly basis on the cover of our Quarterly Report on Form 10-Q or on our Annual Report on Form 10-K. You can view our quarterly and annual reports here.
Privia Health’s independent auditor is PriceWaterhouseCoopers LLP.
Privia Health’s legal counsel is Davis Polk & Wardell LLP located in New York, NY.
To view the latest corporate press releases and earnings announcements, click here.
You may view our latest financial report electronically on our website under News & Events as well as SEC Filings. To sign up for email notifications, click here.
Our 10-K, 10-Q, and 8-K filings are available electronically here.
Please email IR@priviahealth.com or call 817-783-4841. Please direct any media/PR inquiries to priviapress@priviahealth.com and visit our corporate website for other inquiries.